ALPS ETF Trust has released its latest NPORT-P filing, providing crucial insights into its financial health as of August 31, 2026. This filing is significant as it reflects the company's ongoing commitment to transparency and regulatory compliance within the investment management sector.
According to the filing, ALPS ETF Trust reported total assets of approximately $57.6 million and net assets of about $56.9 million. The report also indicated total liabilities of approximately $717,894.37. These figures underscore the trust's solid financial standing and its ability to manage assets effectively.
Background
ALPS ETF Trust, identified by CIK 0001414040, operates in the investment sector. The trust is known for its focus on exchange-traded funds (ETFs) and aims to provide investors with a diverse range of investment opportunities. The most recent filing, dated October 29, 2026, is part of a series of NPORT-P submissions, which are essential for maintaining transparency in the investment management industry.
What the Filing Says
The NPORT-P filing states, "Total assets: $57,606,766.86; Total liabilities: $717,894.37; Net assets: $56,888,872.49." These figures highlight the financial stability of the ALPS ETF Trust as it navigates the complexities of the investment landscape.
Impact
This filing may affect various stakeholders, including investors, regulatory bodies, and competitors within the investment management sector. The data provided in the report is vital for investors looking to understand the trust's financial health and for regulators monitoring compliance with industry standards.
What's Next
The filing does not specify what happens next regarding ALPS ETF Trust's operations or future filings. However, ongoing transparency and regular updates are expected as part of the trust's commitment to its stakeholders.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






